Search for Clinical Trial Results
Rhabdoid Tumor - 22 Studies Found
Status | Study |
NOT_YET_RECRUITING |
Study Name: Trial of Idasanutlin and Selinexor Therapy for Children With Progressive/Relapsed AT/RT or Extra-CNS Malignant Rhabdoid Tumors Condition: Rhabdoid Tumor Date: 2024-05-19 Interventions: Patients will receive idasanutlin dosed once daily on Days 1-5 of a 28-day cycle starting with 80% of the RP2D determined in the ongoing pediatric iMA |
RECRUITING |
Study Name: Tazemetostat+Nivo/Ipi in INI1-Neg/SMARCA4-Def Tumors Condition: Atypical Teratoid Rhabdoid Tumor Date: 2024-05-19 Interventions: oral, twice daily, dosage per protocol |